A Decade of Drug-Eluting Technology in Peripheral Arterial Disease: Blurred by Dissembling Evidence

Por Reekers, J. A., de Vries, C. J. M.
Publicado no Cardiovasc Intervent Radiol (2016)

A polymorphic Xba I site within the human von Willebrand factor (vWF) gene identified by a vWF cDNA clone.

Por Quadt, R, Verweij, C L, de Vries, C J, Briët, E, Pannekoek, H
Publicado em 1986

Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene.

Por Verweij, C L, de Vries, C J, Distel, B, van Zonneveld, A J, van Kessel, A G, van Mourik, J A, Pannekoek, H
Publicado em 1985

Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction

Por Velders, M. A., van Boven, A. J., Brouwer, J., Smits, P. C., van ’t Hof, A. W. J., de Vries, C. J., Queré, M., Hofma, S. H.
Publicado em 2014

RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists: Study design, objectives and expected results

Por Jørstad, H.T., Alings, A.M.W., Liem, A.H., von Birgelen, C., Tijssen, J.G.P., de Vries, C.J., Lok, D.J.A., Kragten, J.A., Peters, R.J.G.
Publicado em 2009